Stock listing

Capricor Therapeutics, Inc.

Selected listing: 4LN2 · DUS · EUR · DE

Capricor Therapeutics, Inc. (Dusseldorf:4LN2), Health Technology. Latest release Oct 5, 2026: Capricor Therapeutics Presents Positive HOPE-3 Open-Label…

4LN2:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:4LN2
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Dusseldorf
Currency: EUR

Latest news from Capricor Therapeutics, Inc.

Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress

October 4, 2026

Capricor Therapeutics, Inc. (CAPR) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 28, 2026

September 22, 2026

CAPR DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - CAPR

September 18, 2026

Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 28, 2026 Deadline

September 17, 2026

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

September 17, 2026

All Capricor Therapeutics, Inc. news →

Events

Replays

Capricor Therapeutics, Inc. (CAPR) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 04:30 PM ET
Watch
Capricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call
Tue, May 12, 2026 · 04:30 PM ET
Watch
Capricor Therapeutics, Inc. (CAPR) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 04:30 PM ET
Watch

Research Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. company profile

View the public company page for Capricor Therapeutics, Inc. on 6ix.

Capricor Therapeutics, Inc. news

Read company news and market updates connected to Capricor Therapeutics, Inc..

Capricor Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Capricor Therapeutics, Inc..